福安药业2月3日获融资买入672.10万元，融资余额3.60亿元

Group 1 - On February 3, Fu'an Pharmaceutical's stock increased by 1.37%, with a trading volume of 59.77 million yuan [1] - The financing data on the same day showed a financing purchase amount of 6.72 million yuan and a financing repayment of 8.12 million yuan, resulting in a net financing buy of -1.40 million yuan [1] - As of February 3, the total balance of margin trading for Fu'an Pharmaceutical was 360 million yuan, which is 6.83% of its circulating market value, indicating a low level compared to the past year [1] Group 2 - As of January 30, the number of shareholders for Fu'an Pharmaceutical was 39,100, an increase of 0.54% from the previous period, while the average circulating shares per person decreased by 0.53% to 24,795 shares [2] - For the period from January to September 2025, Fu'an Pharmaceutical reported an operating income of 1.315 billion yuan, a year-on-year decrease of 34.08%, and a net profit attributable to shareholders of 166 million yuan, down 44.87% year-on-year [2] - Since its A-share listing, Fu'an Pharmaceutical has distributed a total of 688 million yuan in dividends, with 202 million yuan distributed in the last three years [2]